• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zim Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4284.0
  • ISIN : INE518E01015
107.43 -3 (-2.37%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    107.00

  • Today’s High

    110.66

  • Open

    110.00

  • Perv Close

    110.04

  • 52W Low

    79.49

  • 52W High

    128.90

Key Indicators

  • P/E(TTM)

    44.75

  • Mar.Cap (₹Cr.)

    523.46

  • Div & Yield %

    0.00

  • Book Value(₹)

    49.90

  • Debt-Equity Ratio

    -2.37

  • AGM Date

    01-Aug-2025

  • EPS

    2.41

  • P/E Ratio

    44.75

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    523.46

  • RONW (%)

    7.86

  • ROCE (%)

    9.97

Score Board

  • Equity (₹ in Cr.)

    48.73

  • BV (₹)

    49.90

  • Sales( ₹ in Cr.)

    375.64

  • NP (in Cr.)

    11.74

  • NP Var(%)

    -30.0

  • Div%

    0.0

  • CPS (₹)

    6.50

  • EPS (₹)

    2.40

  • Traded Value (₹ in Lakhs)

    525.51

  • 52 Week High

    128.90

  • 52 Week Low

    79.49

  • Price BSE

    108.0

  • Price NSE

    107.00

  • Market Capital( in Cr.)

    525.51

  • P/C Ratio

    16.60

  • P/E Ratio

    44.80

  • Price Vs.BV

    2.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 375.64 365.47 396.53 329.49 303.63 274.32
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 375.64 365.47 396.53 329.49 303.63 274.32
Other Income 5.62 4.69 6.43 4.51 2.45 4.66
Stock Adjustments -1.27 14.05 -16.46 9.67 1.11 6.40
Total Income 379.99 384.21 386.50 343.67 307.19 285.38
EXPENDITURE :            
Raw Materials 166.58 185.49 182.37 170.02 159.74 149.54
Power and Fuel Cost 17.39 13.47 11.09 9.14 7.04 7.47
Employee Cost 56.41 50.81 46.47 38.63 34.48 34.58
Other Manufacturing Expenses 32.14 31.97 27.30 23.76 19.02 22.37
Selling and Administration Expenses 52.04 51.66 55.69 54.44 43.70 40.96
Miscellaneous Expenses 6.54 6.03 5.95 5.24 9.12 6.01
Employee Benefit Expenses 56.41 50.81 46.47 38.63 34.48 34.58
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 331.10 339.42 328.87 301.23 273.11 260.94
Operating Profit 48.89 44.79 57.63 42.44 34.08 24.43
Interest 11.39 6.92 5.58 8.31 10.89 12.65
Gross Profit 37.50 37.87 52.05 34.13 23.19 11.78
Depreciation 19.89 14.83 16.13 14.84 14.61 13.27
Profit Before Tax 17.61 23.04 35.92 19.29 8.58 -1.49
Current Tax 4.45 0.83 6.28 3.40 0.02 -0.12
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.42 5.45 4.63 2.88 2.95 -3.10
Reported Net Profit 11.74 16.76 25.01 13.01 5.62 1.74
Extraordinary Items 0.00 -0.01 0.00 0.00 -3.39 -0.01
Adjusted Net Profit 11.74 16.77 25.01 13.01 9.01 1.75
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.49
P & L Balance brought forward 152.73 136.36 111.81 98.76 93.52 92.54
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.54 0.38 0.46 -0.05 0.39 1.24
P & L Balance carried down 163.94 152.73 136.36 111.81 98.76 93.52
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.41 3.44 5.13 8.01 3.46 1.08
Earnings Per Share(Adj)-Unit Curr 2.41 3.44 5.13 2.67 1.15 0.36
Book Value 49.90 47.60 39.85 104.73 96.69 93.79
Book Value(Adj)-Unit Curr 49.90 47.60 39.85 34.91 32.23 31.26

Shareholding Pattern

  • Promoter Group

    33.26%

  • Public Share Holding

    66.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,207,980 33.26 16,207,980 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,207,980 33.26 16,207,980 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 16,675 0.03 16,675 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 115,780 0.24 115,780 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 132,455 0.27 132,455 6
2] Non Institution
Bodies Corporate 3,841,670 7.88 3,793,670 112
Clearing Members 0 0.00 0 0
Directors of their Relatives 718,337 1.47 718,137 8
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,149,170 4.41 668,662 258
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 432,082 0.89 431,482 357
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 14,558,445 29.88 14,513,325 62
Individuals holding nominal share capital up to Rs. 1 lakh 8,586,497 17.62 7,670,797 15,819
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,745,960 3.58 1,745,960 1
Sub Total 32,385,379 66.46 29,895,251 16,629
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 48,725,814 100.00 46,235,686 16,641

Company Background

Zim Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zim Laboratories Ltd
  • BSE Code : 4284.0
  • ISIN : INE518E01015

  • Incorporation Year

    1984

  • Registered Office

    Sadoday Gyan (Gr Floor)
    Opp NADT Nelson Square, Nagpur,
    Maharashtra-440013

  • Telephone

    91-712-2588070

  • FAX

  • Chairman

    Anwar S Daud

  • Managing Director

    Anwar S Daud

  • Company Secretary

    Piyush Nikhadi

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Zim Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zim Laboratories 107.85 381.26 375.64 44.75 8.21
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10